A daily resveratrol supplement used for 3 months improved glycemic control in a small study of Indian patients with type 2 diabetes who were already taking oral hypoglycemic agents, found researchers from the JSS College of Pharmacy in Tamilnadu, India. Key Point: Oral supplementation of resveratrol improves glycemic control and…
Read more »
mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association A recent study found that adding exenatide twice daily is superior to glimepiride once daily to achieve glycemic control in patients with type 2 diabetes who can’t achieve control on metformin. “These results are important because they highlight…
Read more »
An estimated 50.8 million people in India are living with diabetes, according to the World Diabetes Foundation. Diabetes results in complications ranging from retinopathy and neuropathy to coronary artery disease. Epidemiological demand combined with increased complexity of care make evidence-based treatment guidelines vital for busy clinicians. The American College of…
Read more »
The addition of metformin to insulin therapy in patients with type 2 diabetes does not significantly impact all-cause or cardiovascular mortality, although the combination reduced hemoglobin A1C values, weight gain, and insulin doses, a recent study found. Combining metformin to insulin also may increase the risk of hypoglycemia. According to…
Read more »
According to the International Diabetes Federation (IDF), 50.8 million Indians (7.1% of adults) suffer from diabetes, making India the country with the most diabetics worldwide. The IDF estimates that diabetes kills about 1 million residents of India each year. In a new joint position statement published by the American Diabetes…
Read more »
While all of the oral medications approved to treat type 2 diabetes mellitus (T2DM) effectively lower blood glucose, each medication’s effects on other clinical events vary. The costs of these drugs also vary. A recent study of 254,973 T2DM patients who were newly initiated on oral hypoglycemic monotherapy examined prescribing…
Read more »
indicates a Peer-Reviewed Article
Early intensive therapy in type 2 diabetes may preserve beta cell function
mdCurrent Conference Report: 72nd annual scientific sessions of the American Diabetes Association Intensive therapy initiated in newly diagnosed patients with type 2 diabetes preserved beta-cell function over the course of a 3.5-year study. The study’s lead investigator, Ildiko Lingvay, MD, recommended that “we try to achieve glycemic normalization as quickly…
Read more »